Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Novartis Centre de Recherche Santé Animale S.A., commonly referred to as Novartis Animal Health, is a leading player in the veterinary pharmaceutical industry, headquartered in Switzerland (CH). Established in the early 2000s, the company has made significant strides in animal health, focusing on innovative solutions for livestock and companion animals.
With a strong presence in Europe and North America, Novartis Animal Health is renowned for its comprehensive portfolio of products, including vaccines, anti-infectives, and parasiticides. Their commitment to research and development has led to unique offerings that enhance animal welfare and productivity.
Recognised for its contributions to veterinary medicine, Novartis Animal Health continues to solidify its market position through strategic partnerships and a dedication to advancing animal health solutions.
+70 vs industry average
Novartis Centre de Recherche Sante Animale S.A.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Novartis Centre de Recherche Sante Animale S.A. yet.
Novartis Centre de Recherche Sante Animale S.A., headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The organisation is a current subsidiary of Novartis AG, which cascades its climate commitments and initiatives down to its subsidiaries.
Novartis AG has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, CDP participation, and RE100 membership, all of which are relevant to Novartis Centre de Recherche Sante Animale S.A. These initiatives aim to enhance sustainability and reduce carbon footprints across the organisation. However, specific reduction targets or achievements for Novartis Centre de Recherche Sante Animale S.A. have not been disclosed.
As a subsidiary, Novartis Centre de Recherche Sante Animale S.A. aligns with the broader climate strategies set forth by Novartis AG, which include commitments to reduce greenhouse gas emissions and improve environmental performance. The lack of specific emissions data highlights the need for further transparency and reporting in line with industry standards.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Novartis Centre de Recherche Sante Animale S.A. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Novartis Centre de Recherche Sante Animale S.A. yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more